Physician profile
Ashoke Agarwal
NPI 1780649608
$2,483.72
in general payments reported to CMS, 2019-2025
18 companies · $79.19 in 2025
The $79.19 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,028 · 2020: $200 · 2021: $353 · 2022: $302 · 2023: $326 · 2024: $193 · 2025: $79.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $599.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $856.34 | 2019 | |
| Boston Scientific Corporation | $397.83 | 2020-2023 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $145.66 | 2019-2021 | |
| Abiomed | $138.86 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.00 | 2022 | |
| Terumo Medical Corporation | $108.66 | 2023-2024 | Angio-Seal, Glidewire, Glidesheath Slender |
| Shockwave Medical, INC | $96.88 | 2023-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $92.20 | 2019-2022 | |
| Abbott Laboratories | $90.31 | 2020-2024 | Diamondback Peripheral, Cardiomems |
| Medtronic, INC. | $89.64 | 2023-2024 | Corevalve Evolut R, Chameleon |
| Medtronic Vascular, INC. | $89.39 | 2019 | |
| Cardiovascular Systems INC. | $82.70 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $48.16 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $42.36 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $31.86 | 2024 | Gardasil, Gardasil 9, Capvaxive |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $18.22 | 2025 | Gore Cardioform Septal Occluder |
| Lilly USA, LLC | $14.98 | 2020 | |
| Sanofi Pasteur INC. | $14.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashoke Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.